NCT03866551View on ClinicalTrials.gov

Reprieve ADHF EFS IDE

NAUnknownINTERVENTIONAL
Enrollment

40

Participants

Timeline

Start Date

May 1, 2019

Primary Completion Date

December 1, 2019

Study Completion Date

February 1, 2020

Conditions
Congestive Heart Failure
Interventions
DEVICE

Reprieve Cardiovascular System

The Reprieve Cardiovascular System (RCS) shall be utilized to maximize fluid removal over a maximum duration of 72 hours.

Sponsors
All Listed Sponsors
lead

CardioRenal Systems, Inc.

INDUSTRY

NCT03866551 - Reprieve ADHF EFS IDE | Biotech Hunter | Biotech Hunter